You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰格醫藥(300347.SZ):擬出售參股公司禮新醫藥股權

格隆匯7月17日丨泰格醫藥(300347.SZ)公佈,禮新醫藥科技(上海)有限公司(簡稱“禮新醫藥”或“標的公司”)擬將95.09%股權轉讓給正大製藥投資(北京)集團有限公司(簡稱“正大製藥”或“買方”)。公司作爲禮新醫藥參股股東,在全面分析創新藥市場、標的公司的核心技術和經營情況後,擬同意標的公司的出售安排,配合其將泰格股權直接持有禮新醫藥的全部股權以對價約3,411萬美元轉讓給買方,並簽署相關交易文件。

截至公告披露日,公司通過泰格股權直接持有禮新醫藥股權比例爲3.41%;通過持有基金等份額穿透後間接持有禮新醫藥股權比例爲4.58%。公司在禮新醫藥無董事席位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account